Factors that govern the specificity of an antisense oligonucleotide (O
N) for its target RNA include accessibility of the targeted RNA to ON
binding, stability of ON/RNA complexes in cells, and susceptibility of
the ON/RNA complex to RNase H cleavage. ON specificity is generally p
roposed to be dependent on its length. To date, virtually all previous
antisense experiments have used 12-25 nt-long ONs. We explored the an
tisense activity and specificity of short (7 and 8 nt) ONs modified wi
th C-5 propyne pyrimidines and phosphorothioate internucleotide linkag
es. Gene-selective, mismatch sensitive, and RNase H-dependent inhibiti
on was observed for a heptanucleotide ON. We demonstrated that the fla
nking sequences of the target RNA are a major determinant of specifici
ty. The use of shorter ONs as anti-sense agents has the distinct advan
tage of simplified synthesis. These results may lead to a general, cos
t-effective solution to the development of antisense ONs as therapeuti
c agents.